The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9518015 B1

PDF
Full Text
Expired
Date of Patent:
Dec. 13, 2016

Filed:

Sep. 14, 2012
Applicants:

Antoni Torrens Jover, Terrassa, ES;

Ramon Mercè Vidal, Barcelona, ES;

Francesc Xavier Caldentey Frontera, Tarragona, ES;

Antonio David Rodríguez Garrido, O Grove, ES;

Elena Carceller González, Sant Cugat Del Vallés, ES;

Jordi Salas Solana, Granollers, ES;

Inventors:

Antoni Torrens Jover, Terrassa, ES;

Ramon Mercè Vidal, Barcelona, ES;

Francesc Xavier Caldentey Frontera, Tarragona, ES;

Antonio David Rodríguez Garrido, O Grove, ES;

Elena Carceller González, Sant Cugat Del Vallés, ES;

Jordi Salas Solana, Granollers, ES;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 209/12 (2006.01); C07D 209/34 (2006.01); C07D 405/06 (2006.01); C07D 209/42 (2006.01); C07D 215/48 (2006.01); C07D 235/06 (2006.01); C07D 471/04 (2006.01); C07D 209/08 (2006.01); C07D 231/56 (2006.01); C07D 401/06 (2006.01); C07D 405/12 (2006.01); C07D 241/42 (2006.01); C07D 487/04 (2006.01); C07D 265/36 (2006.01);
U.S. Cl.
CPC ...
C07D 209/42 (2013.01); C07D 209/08 (2013.01); C07D 209/12 (2013.01); C07D 209/34 (2013.01); C07D 215/48 (2013.01); C07D 231/56 (2013.01); C07D 235/06 (2013.01); C07D 241/42 (2013.01); C07D 265/36 (2013.01); C07D 401/06 (2013.01); C07D 405/06 (2013.01); C07D 405/12 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01);
Abstract

The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.


Find Patent Forward Citations

Loading…